Source comparison
Post-Workout vs Pre-Workout Timing Comparison
Pre-workout (30–60 min before) Coincides with warm-up and working sets High. Peptide present during ATP depletion +340% (study: Cell Metabolism 2022) Citrate synthase +38%, COX IV +42% Amplifies exercise-induced adaptive signalling when metabolic demand is hig
This comparison does not assign a generated winner or score.
- Pre-workout (30–60 min before)
- Coincides with warm-up and working sets
- High. Peptide present during ATP depletion
- +340% (study: Cell Metabolism 2022)
- Citrate synthase +38%, COX IV +42%
- Amplifies exercise-induced adaptive signalling when metabolic demand is highest
- Optimal for mitochondrial biogenesis and glucose uptake. Timing synchronises mechanism with stimulus
- Post-workout (0–2 hours after)
- Occurs during inflammation phase, after AMPK peak
- Low. Metabolic stress resolved before peptide availability
- +60% (minimal improvement vs control)
- Citrate synthase +8%, COX IV negligible
- May support glycogen resynthesis but misses AMPK-dependent transcription window
- Suboptimal. Peptide arrives after the signalling cascade has closed; waste of dosage
- Rest day administration (no exercise)
- Variable. No exercise stimulus present
- None. AMPK remains at basal levels without energy deficit
- No measurable increase
- No change vs baseline
- Theoretical receptor sensitisation (unproven in human trials)
- Not recommended. MOTS-c requires metabolic stress to function; no stress = no adaptation
- The mechanistic difference is unambiguous: MOTS-c enhances mitochondrial adaptation during the metabolic challenge, not after inflammation and repair pathways have already initiated. Post-workout timing treats the peptide like a conventional recovery compound (similar to BPC-157 or TB-500), but MOTS-c doesn't accelerate tissue repair. It amplifies the cellular response to energy deficit. Administering it when no deficit exists wastes both the compound and the injection.